BUSINESS4 years ago
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Reports A Loss Of $9.6 Million In Q4 2020
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) reports a net loss of $9.6 million in Q4 2020. Its R&D expenses and G&A (General and Administrative) expenses are $5.6 million...